Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Hims & Hers Health Inc (NY: HIMS )

13.65 -0.78 (-5.41%)
Official Closing Price Updated: 7:00 PM EDT, Sep 6, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 9,235,455
Open 14.31
Bid (Size) 13.69 (50)
Ask (Size) 13.80 (24)
Prev. Close 14.43
Today's Range 13.47 - 14.42
52wk Range 5.650 - 25.74
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Battle Over Compounded Weight-Loss Medications - Sustainability and Regulation
Explore how Hims & Hers competes with big pharma amid weight-loss drug shortages, offering cheaper alternatives and facing sustainability challenges. 
Via Benzinga
Eli Lilly Just Made Zepbound Even More Appealing. Here's What Smart Investors Need to Know.
Lilly just lowered the price of Zepbound. 
Via The Motley Fool

Performance

YTD
+41.60%
+41.60%
1 Month
-14.90%
-14.90%
3 Month
-34.34%
-34.34%
6 Month
-4.28%
-4.28%
1 Year
+101.92%
+101.92%

More News

Read More
Got $1,000? 3 Healthcare Stocks to Buy and Hold Forever
Via The Motley Fool
Billionaires Are Buying Hims & Hers Health Hand Over Fist. Should You Follow Their Lead?
Via The Motley Fool
2 No-Brainer Growth Stocks to Buy With $200 Right Now
Via The Motley Fool
Is Hims & Hers Health Stock a Buy?
Via The Motley Fool
What Is Going On With Hims & Hers Stock?
Via The Motley Fool
The Latest Analyst Ratings For Hims & Hers Health
Via Benzinga
Looking Into Hims & Hers Health's Recent Short Interest
Via Benzinga
Stock Market Rally Mixed; Dow Jones Hits High While Nvidia Tumbles On Earnings: Weekly Review
Via Investor's Business Daily
Topics Stocks
Exposures US Equities
Why Hims & Hers Health Stock Was Falling This Week
Via The Motley Fool
Why Hims & Hers Stock Crashed on Tuesday
Via The Motley Fool
Why Hims & Hers Health Stock Is Falling
Via Benzinga
Hims & Hers Health Unusual Options Activity For August 13
Via Benzinga
American Woodmark Reports Downbeat Results, Joins Snowflake And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Via Benzinga
Eli Lilly Halves Zepbound Price In New Version Of Weight-Loss Drug
Via Investor's Business Daily
Hims & Hers Health Sees Major Growth Opportunity In Booming Weight Loss Market, Says Analyst
Via Benzinga
Telehealth Firm Hims & Hers Health Rides High On Demand for Copycat Weight Loss Drugs Amid Supply Shortages
Via Benzinga
2 Magnificent Stocks That Are Screaming Buys in August
Via The Motley Fool
Is Hims & Hers Health the Best Growth Stock for You?
Via The Motley Fool
Prediction: Up 74% So Far This Year, This Weight Loss Stock Is About to Crater
Via The Motley Fool
This 1 Piece of Good News for Eli Lilly Is Bad News for Hims & Hers Health Stock
Via The Motley Fool
Top 3 Stocks to Watch: Options Traders Bet on Big Gains
Via MarketBeat
Topics Stocks
Exposures US Equities
Hims & Hers Health Boosts Outlook. Is This a Golden Opportunity to Buy the Stock?
Via The Motley Fool
MarketBeat Week in Review – 8/5 - 8/9
Via MarketBeat
Topics Economy
Exposures Economy Interest Rates
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.